827 – Maternal and Infant Predictors of Mortality in Liveborn Infants in the IMPAACT 2010 (VESTED) Trial
Background The IMPAACT 2010 (VESTED) randomized trial compared dolutegravir (DTG) plus emtricitabine/tenofovir alafenamide fumarate (FTC/TAF); DTG plus FTC/tenofovir disoproxil fumarate (TDF) and efavirenz (EFV)/FTC/TDF initiated during pregnancy among 643 women in 9 countries (predominantly in Africa). Previous analyses showed superior virologic efficacy and pregnancy outcomes with DTG-based compared with EFV-based ART. We conducted an exploratory…